Allogene Therapeutics, Inc. (ALLO) Tops Q1 EPS by 1c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• Jana urging Fiserv to double planned cost ‌cuts, use Palantir’s products help with technology transformation program - Reuters
• Top Canadian Tech Leaders and Investors to Speak at Cantech Investment Conference 2026